OKUR   $4.38  2.10% Market Closed

OnKure Therapeutics, Inc.

Current temperature: 7.19
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 5
Target Price Mean 23.80
Mean unverified/preliminary 23.80 / 23.80
Target Price Low / High 16.00 / 30.00
Median / STD DEV 27.00 / 6.76
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Buy ActivelyBuy None
macd None None None
stoch None None None
ma20 None ActivelyBuy None
ma50 ActivelyBuy None None
ma100 ActivelyBuy ActivelyBuy ActivelyBuy
Candlestick PatternMarch 12, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US68277Q1058
ceo Dr. Nicholas A. Saccomano Ph.D.
Website https://onkuretherapeutics.com
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops biologically validated drivers of cancers medicines in the United States. The company's lead product candidate is the OKI-219, a selective inhibitor of PI3Ka harboring the H1047R mutation for the treatment of solid tumors, including breast cancer that is in Phase 1 clinical trial. OnKure Therapeutics, Inc. is headquartered in Boulder, Colorado.